elegslab
Activeelegslab accelerates drug discovery with AI-automated C. elegans platforms—a next-generation NAMs solution.
What it does
elegslab (엘렉스랩) is a Korea-based biotech and AI company developing an end-to-end drug discovery platform that integrates automated lab devices, biochips, and AI-driven analytics. The company enables high-throughput in vivo screening and predictive modeling of drug efficacy and toxicity, helping pharmaceutical, biotech, and related industries accelerate R&D with standardized, data-driven insights.
Its site says now · captured 2026-08-23
elegslab | 예쁜꼬마선충 AI 전임상 CRO·나노제제 CDMO
elegslab은 예쁜꼬마선충(C. elegans) 기반 AI 플랫폼으로 의약·건강기능식품·화장품의 효능과 독성을 동시에 평가하는 전임상 CRO이자 나노제제 CDMO입니다. 동물대체시험으로 신약개발 기간과 비용을 줄여드립니다.
Next to it in Healthcare and bio · AI-automated drug discovery with C. elegans
- Axiom TherapeuticsPlug and Play PnP 2025
AI-powered covalent drug discovery for untreatable cancers
- RasynY Combinator S26
Towards a General Intelligence for Chemistry
- WonderTxY Combinator S26
Extrapolative AI to unlock First-in-Class drugs
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease
- Door PharmaPlug and Play PnP 2025
Door Pharma is a discovery phase biotech company that focuses on virus structural proteins as antiviral targets. The hypothesis underlying our work is that formation of an infectious virus requires the right interplay between viral components.
- Anto BiosciencesY Combinator F25
A Foundation Model for Microbial Communities.
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.